黑色素瘤细胞和免疫疗法的进步
Tanase Timis1,2, Sanda Buruiana3, Delia Dima4
1Department of Hematology, Iuliu Hațieganu University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.
Biomedicines
|January 25, 2025
概括
全球皮肤黑色素瘤发病率正在上升. 免疫疗法的进步,就像免疫检查点抑制剂一样,显示出有希望但有局限性,推动研究新的治疗方法,以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 皮肤病学 皮肤病学
背景情况:
- 全球皮肤黑色素瘤的发病率正在增加,这与紫外线暴露和人口老龄化有关.
- 尽管诊断和治疗方法得到了改进,但黑色素瘤由于其侵略性和转移潜力,仍然是一个公共卫生挑战.
- 黑色素瘤具有高度免疫性,对免疫疗法反应良好,需要创新的免疫驱动的治疗策略.
研究的目的:
- 审查当前黑色素瘤治疗的现状,重点关注免疫疗法的进展.
- 突出现有治疗方法的局限性和需要新的方法.
- 探索新兴的治疗方式和正在进行的黑色素瘤管理的研究方向.
主要方法:
- 在黑色素瘤治疗当前研究和临床试验的文献综述.
- 分析已批准的免疫疗法,包括免疫检查点抑制剂 (抗PD-1,抗CTLA-4).
- 探索新的和新兴的治疗策略,如采用细胞疗法和型病毒疗法.
主要成果:
- 经批准的免疫疗法改善了黑色素瘤的存活率.
- 目前治疗方法的局限性包括低响应率,耐药性和毒性.
- 新兴的疗法,如TILs和型病毒疗法显示出潜力,而CAR-T细胞疗法在黑色素瘤中面临挑战.
结论:
- 继续研究和开发先进的黑色素瘤治疗方法至关重要.
- 需要新的治疗策略来克服当前的治疗局限性并改善患者的治疗结果.
- 黑色素瘤管理方面的进展为更有效的预防,诊断和治疗提供了希望.
相关概念视频
Tumor Immunotherapy
466
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
466
Cancer Vaccines
330
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
330
Skin Cancer
3.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
3.1K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cytotoxic T Cells-mediated Immune Response
835
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
835
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K


